Literature DB >> 9242848

Lifetime and 12-month prevalence of DSM-III-R mental disorders among the homeless in Madrid: a European study using the CIDI.

C Vázquez1, M Muñoz, J Sanz.   

Abstract

The characteristics of homeless people in Europe are almost unknown. The aim of this study was to describe the lifetime and 12-month prevalence of DSM-III-R/CIDI mental disorders among the homeless population of Madrid. A total of 261 homeless subjects, sampled from different sites, participated in the study. In terms of DSM-III-R lifetime rates, 50% of the sample had substance-related disorders and 35% had non-substance-related disorders. In total, 67% of the study subjects had some type of disorder. The lifetime prevalence of schizophrenia (4%) was lower than reported in most previous studies. Although the mental illness pattern is similar to that observed in studies using the same diagnostic methods, the results reported here show a lower prevalence of drug abuse and schizophrenic disorders. The reasons for these cultural differences and their implications for international public health research are discussed.

Entities:  

Mesh:

Year:  1997        PMID: 9242848     DOI: 10.1111/j.1600-0447.1997.tb10141.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  13 in total

1.  Three year course and outcome of mental illness in homeless men: a prospective longitudinal study based on a representative sample.

Authors:  Manfred M Fichter; Norbert Quadflieg
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2004-11-12       Impact factor: 5.270

Review 2.  Importance of clinical diagnoses for comorbidity studies in substance use disorders.

Authors:  Marta Torrens; Rocío Martin-Santos; Sharon Samet
Journal:  Neurotox Res       Date:  2006-12       Impact factor: 3.911

3.  Mental disorder, service use, and barriers to care among 500 homeless people in 3 different urban settings.

Authors:  Reinhardt Michael Krausz; Adam F Clarkson; Verena Strehlau; Iris Torchalla; Kathy Li; Christian G Schuetz
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2013-01-09       Impact factor: 4.328

4.  Prevalence of mental illness among homeless men in the community--approach to a full census in a southern German university town.

Authors:  Gerhard Längle; Birgit Egerter; Friederike Albrecht; Monika Petrasch; Gerhard Buchkremer
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2005-05       Impact factor: 4.328

5.  Epidemiology of major depressive episode in a southern European country: results from the ESEMeD-Spain project.

Authors:  Andrea Gabilondo; Sonia Rojas-Farreras; Gemma Vilagut; Josep M Haro; Ana Fernández; Alejandra Pinto-Meza; Jordi Alonso
Journal:  J Affect Disord       Date:  2010-01       Impact factor: 4.839

6.  Prevalence of psychiatric disorders among homeless people in Athens area: a cross-sectional study.

Authors:  Michael G Madianos; Paraskevi Chondraki; George N Papadimitriou
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2013-03-19       Impact factor: 4.328

Review 7.  The Prevalence of Mental Illness in Homeless People in Germany.

Authors:  Stefanie Schreiter; Felix Bermpohl; Michael Krausz; Stefan Leucht; Wulf Rössler; Meryam Schouler-Ocak; Stefan Gutwinski
Journal:  Dtsch Arztebl Int       Date:  2017-10-06       Impact factor: 5.594

8.  Relationship between adverse childhood experiences and homelessness and the impact of axis I and II disorders.

Authors:  Leslie E Roos; Natalie Mota; Tracie O Afifi; Laurence Y Katz; Jino Distasio; Jitender Sareen
Journal:  Am J Public Health       Date:  2013-10-22       Impact factor: 9.308

Review 9.  A systematic review of the prevalence of schizophrenia.

Authors:  Sukanta Saha; David Chant; Joy Welham; John McGrath
Journal:  PLoS Med       Date:  2005-05-31       Impact factor: 11.069

Review 10.  The prevalence of mental disorders among the homeless in western countries: systematic review and meta-regression analysis.

Authors:  Seena Fazel; Vivek Khosla; Helen Doll; John Geddes
Journal:  PLoS Med       Date:  2008-12-02       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.